Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

59459 1490631916HCLSReviewIrelandMarch2017.pdf
Energy Boardroom

Advair slide, China woes drop-kick Glaxo profits in Q1

30.04.2014 / Fierce Pharma

Things are changing at GlaxoSmithKline, but not fast enough to avoid the 18% plunge in first-quarter profits the company reported Monday. But with big moves underway–including the introduction of new respiratory products, a giant asset swap and consumer venture with Novartis and a marketing clean-up in China–CEO Andrew Witty doesn't expect the skid to last long.

Cover_HCLS_Ireland LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: